Awareness among parents of children with thalassemia major

Journal of the Pakistan Medical Association

Volumn 58, Issue 11, 2008, Pages 621-624

  Arif, Fehmina ^a   Fayyaz, Jabeen ^a   Hamid, Ahmer ^a  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE MESYLATE;

ARTICLE; AWARENESS; BLOOD TRANSFUSION; HUMAN; INFUSION PUMP; NORMAL HUMAN; PAKISTAN; PRENATAL DIAGNOSIS; QUESTIONNAIRE; SCREENING; SOCIOECONOMICS; THALASSEMIA MAJOR;

ADOLESCENT; AWARENESS; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CONSANGUINITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; MALE; PARENTS; QUESTIONNAIRES;

EID: 56049088523     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Takeshita K. Thalassemia, Beta [online] 2006 [cited 2006 Nov 15]. Available from: URL: http://www.emedicine.com/med/topic2260.html.
2. Khateeb B, Moatter T, Shaghil AM, Haroon S, Kakepoto GN. Genetic diversity of beta-thalassemia mutations in Pakistani population. J Pak Med Assoc. 2000; 50:293-96.
3. Lodhi Y. Economics of thalassemia management in Pakistan. In Thalassemia Awareness Week, Ed. Ahmed S. Friends of Thalassemia 2003.
4. Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med. 2002 10; 347:1162-68.
5. Bittles AH. The role and significance of consanguinity as a demographic variable. Popul Dev Rev 1994; 20:561-84.
6. Rahman MU, Lodhi Y. Prospects and future of conservative management of beta thalassemia major in a developing country. Pak J Med Sci 2004; 20:105-12.
7. Hassan K, Aslam M, Ikram N. Parental knowledge and awareness in cases of thalassemia major. J Pak Inst Med Sci 2002; 13: 623-26.
8. Kaczorowska-Ha? B, Balcerska A, Zdebska E, Wlaz?owski M. Thalassemia beta in children from Pomerania Region Med Wieku Rozwoj. 2007; 11:69-72.
9. Khattak MF, Saleem M. Prevalence of heterozygous beta-thalassemia in northern areas of Pakistan. J Pak Med Assoc. 1992; 42:32-34.
10. Huang SZ, Zeng FY, Ren ZR, Lu ZH, Rodgers GP, Schechter AN. et al. RNA transcripts of the beta-thalassaemia allele IVS-2-654 C->T: a small amount of normally processed beta-globin mRNA is still produced from the mutant gene. Br J Haematol. 1994; 88:541-46.
11. Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran. Transplant Proc. 2005; 37:4477-81.
12. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C. et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med. 1993 16; 329:840-44.
13. Cao A, Rosatelli C, Galanello R, Monni G, Olla G, Cossu P. et al. The prevention of thalassemia in Sardinia. Clin Genet. 1989; 36:277-85.
14. Buki MK, Qayum I, Siddiqui N. Prevalence and preventive measures for thalassemia in Hazara region of NWFP Pakistan. JAMC 1998; 10: 28-31.
15. Hafeez M, Aslam M, Ali A, Rashid Y, Jafri H. Regional and ethnic distribution of beta thalassemia mutations and effect of consanguinity in patients referred for prenatal diagnosis. J Coll Physicians Surg Pak 2007; 17: 144-47.
16. Karimi M, Nikrooz P, Kashef S, Jamalian N, Davatolhagh Z. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran. Int J Lab Hematol. 2007; 29:321-26.
17. Singh H, Pradhan M, Singh RL, Phadke S, Naik SR, Aggarwal R. et al. High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions. Vox Sang. 2003; 84:292-99.
18. Mollah AH, Nahar N, Siddique MD A. Anwar KS, Hassan T, Azam MD G.Common Transfusion-transmitted Infectious Agents among Thalassaemic Children in Bangladesh. J HEALTH POPUL NUTR 2003; 21:67-71.
19. Kapoor C, Hanif M, Iqbal M. Poly transfused thalassemic patients;prevalence of viral markers and malarial parasite. Professional Med J 2007; 14: 177-80.
20. Shah MA, Khan MT, Ulla Z, Ashfaq NY. Prevalence of Hepatitis B and Hepatitis C virus infection in multitransfused thalassemia major patients in North West Frontier province. Pak J Med Sci 2005; 21: 281-84.
21. Yonus M, Hassan K, Ikram N, Naseem L, Zaheer HA, Khan MF. Hepatitis C virus seropositivity in repeatedly transfused Thalassemia Major patients. Int J Pathol Jun; 2:20-23.
22. Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci. 2005; 1054:445-50.
23. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997 1; 89:739-61.
24. Brittenham GM, Nathan DG, Olivieri NF, Pippard MJ, Weatherall DJ. Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility. Lancet. 2003 11; 361:183-84.
25. Rai MA, Tanoli ZM, Gandapur ASK. Clinical spectrum of patients with beta thalassemia: a review of fifty four patients. Gomal J Med Sci 2005; 3: 55-60.